Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when his Department plans to release an impact assessment for changes to the NICE cost-effectiveness threshold.

There are no plans to publish an impact assessment or details of the modelling in relation to changes to the National Institute for Health and Care Excellence cost-effectiveness threshold. Information included in the impact assessment is commercially sensitive.

The United Kingdom and United States’ pharmaceutical deal is a vital investment that builds on the strength of our National Health Service and world leading life sciences sector.